Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 72319-021

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 72319-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

Chemical structure of ranolazine showing its molecular framework with functional groups including amide, piperazine, hydroxyl, and methoxy-substituted aromatic ring.*

FDA Label Image

Container-1000mg-60tablets (Container 1000mg 60tablets)

Ranolazine Extended-Release Tablets 1,000 mg film-coated tablets by i3 Pharmaceuticals, LLC. The label indicates the product contains 60 tablets, is for oral use, and must be swallowed whole without crushing, breaking, or chewing. Storage instructions and safety warnings about keeping out of reach of children are included. NDC 72319-022-02.*

FDA Label Image

Container-500mg-60tablets (Container 500mg 60tablets)

Label for Ranolazine Extended-Release Tablets 500 mg by i3 Pharmaceuticals, LLC. The label notes the product as film-coated, extended-release tablets with directions to swallow whole and not crush or chew. The bottle contains 60 tablets, with storage instructions and standard warnings including keeping out of reach of children. NDC 72319-021-02 is displayed along with manufacturer contact information and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.